Improving physiological relevance in neurological disease drug development

In this case study, discover how Concept Life Sciences is building more reliable, consistent in vitro assays for neurological disease drug development using ioMicroglia from bit.bio. The adoption has enabled Concept Life Sciences to achieve greater lot-to-lot consistency and scalability in their assays, and the team has successfully used ioMicroglia to optimize microglial phagocytosis assays and test the effects of various stimuli on microglial activity.

Plus, explore how the collaboration with bit.bio also provided valuable technical support, helping Concept Life Sciences integrate these cells into their workflows and build more complex, human-relevant models for their clients.

Resource details:
Resource type: Case Study
Page count: 8
Read time: 12 mins